ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
ACRV
|
Acrivon Therapeutics, Inc.
|
US
|
NASDAQ
|
AEZS
|
AEterna Zentaris Inc.
|
US
|
NASDAQ
|
BCAB
|
BioAtla, Inc.
|
US
|
NASDAQ
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
FUSN
|
Fusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
NEO
|
NeoGenomics, Inc.
|
US
|
NASDAQ
|
SESN
|
Sesen Bio, Inc.
|
US
|
NASDAQ
|
SPPI
|
Spectrum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
TYRA
|
Tyra Biosciences, Inc.
|
US
|
NASDAQ
|
URGN
|
UroGen Pharma Ltd.
|
US
|
NASDAQ
|
IIQ
|
INOVIQ Ltd
|
AU
|
ASX
|
BIOYF
|
Biosyent Inc
|
US
|
OTC
|
IMEXF
|
Imagin Medical Inc.
|
US
|
OTC
|
KHTRF
|
Knight Therapeutics
|
US
|
OTC
|
MXDHF
|
Mdxhealth Sa
|
US
|
OTC
|
PFGTF
|
Pacific Edge Ltd
|
US
|
OTC
|
ROSGQ
|
Rosetta Genomics Ltd
|
US
|
OTC
|
CTEC
|
Convatec Group Plc
|
UK
|
LSE
|
JNJ
|
Johnson & Johnson Co DRC
|
AR
|
BA
|